Animal and cell culture studies further support a role for the GH/ insulin-like growth factor-1 (IGF-1) axis in the pathophysiology of NAFLD and its progression to NASH and fibrosis [11]. Here, GH1 is linked to metabolic dysfunction-associated steatohepatitis.